Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial
Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial
respiratory
With all the focus on coronavirus, let’s not forget the other respiratory viruses
Drazen Zigic/Shutterstock With coronaviruses taking over our news feeds – and lives – you may